At the news
? MIXEDIMPACT 6/10 8-K filed Aug 31, 2026 at 07:05 ET
TELA Bio announced a strategic cost reduction initiative including a 20% workforce reduction (201 to 160 employees) and streamlining of external resources, expected to reduce annual operating expenses by $17.0 million (18%) and extend cash runway into 2028. Simultaneously, CFO/COO Roberto Cuca stepped down effective August 31, 2026, with CEO Heather Getz assuming the principal financial officer role. The company expects a one-time restructuring charge of approximately $1.5 million in Q3 2026.
- Workforce reduction of approximately 20%, from 201 to 160 full-time employees
- Expected annual operating expense reduction of $17.0 million (18%)
- One-time restructuring charge of approximately $1.5 million in Q3 2026
- CFO/COO Roberto Cuca stepped down effective August 31, 2026; departure treated as termination without cause
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access